Response to Anti-hypertensives in Pregnant and Postpartum Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 109 participants.
Also called NCT03506724
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 109 participants
- Registry
-
NCT03506724
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03506724. Randomized; no masking; primary purpose treatment. Start 2017-09-11 (actual); primary completion 2019-04-05 (actual). Results posted on 2021-05-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Response to Anti-hypertensives in Pregnant and Postpartum Patients
- Condition
- Hypertension in Pregnancy
- Condition
- Preeclampsia
- Intervention (Drug)
- Nifedipine
- Intervention (Drug)
- Labetalol
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Collaborator
- Mount Sinai Hospital, New York
- Collaborator
- Maimonides Medical Center
Record details
- Record id
cardio:ct-nct03506724- Content hash
8df8ad0150d12aa3c443490399ff3038822c67e0afc7625f70ac7a02e2db3126